Cargando…
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
OBJECTIVE: To provide the latest evidence for the efficacy and safety of arbidol (umifenovir) in COVID‐19 treatment. METHODS: A literature systematic search was carried out in PubMed, Cochrane Library, Embase, and medRxiv up to May 2021. The Cochrane risk of bias tool and Newcastle–Ottawa scale were...
Autores principales: | Amani, Behnam, Amani, Bahman, Zareei, Sara, Zareei, Mahsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426686/ https://www.ncbi.nlm.nih.gov/pubmed/34347937 http://dx.doi.org/10.1002/iid3.502 |
Ejemplares similares
-
Artesunate, imatinib, and infliximab in COVID‐19: A rapid review and meta‐analysis of current evidence
por: Amani, Bahman, et al.
Publicado: (2022) -
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
por: Nojomi, Marzieh, et al.
Publicado: (2020) -
Antiviral drug Umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: Estimated levels and transformation
por: Ul'yanovskii, Nikolay V., et al.
Publicado: (2022) -
Effect of umifenovir (arbidol) versus standard care
on clinical outcome in patients with COVID-19: a retrospective cohort
study
por: Yi, Wanwan, et al.
Publicado: (2023) -
Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
por: Haviernik, Jan, et al.
Publicado: (2018)